Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arsenicum album is a common homeopathic preparation derived from arsenic trioxide ($As_2O_3$). In homeopathic practice, it is traditionally used for conditions characterized by burning pains, restlessness, and anxiety. Recent clinical and preclinical research, particularly in India, has explored its potential as a prophylactic agent for COVID-19 and as an adjunct therapy for various conditions including glioblastoma multiforme, multiple myeloma, dermatophytosis, and chronic cough. Its proposed mechanisms of action in high dilutions involve metabolic disruption, induction of reactive oxygen species (ROS)-mediated apoptosis, and immunomodulation by affecting cytokine profiles (e.g., reducing IL-6 and IL-1β) and enhancing humoral immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arsenicum album.